An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice

Documenti analoghi

• Immunoassay Detection of SARS ‐ CoV ‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
  di: Robert M. Hnasko, et al.
  Pubblicazione: (2025)
• Oral Immunisation With Non‐ GMO Surface Displayed SARS ‐ CoV ‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice
  di: Robie Vasquez, et al.
  Pubblicazione: (2025)
• A Chip‐Based Surveillance Platform for Detecting Antibody‐Based Immunity and Immune Escape Using SARS‐CoV‐2 Pseudovirus Surrogates
  di: Maisha M. Feroz, et al.
  Pubblicazione: (2025)
• Gene and cell therapy of human genetic diseases: Recent advances and future directions
  di: Busra Cetin, et al.
  Pubblicazione: (2024)
• Lyophilised Reverse Transcriptase and Polymerase for Point‐of‐Care Diagnostics of SARS ‐ CoV ‐2
  di: Natalie Mutter, et al.
  Pubblicazione: (2025)